Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tirzepatide: Dual GIP/GLP-1 Receptor Agonist Tirzepatide activates two receptor types simultaneously: GLP-1: Same appetite suppression and insulin-stimulating benefits as semaglutide GIP (Glucose-dependent insulinotropic polypeptide): Improves insulin sensitivity, influences fat metabolism, and may change how the body responds to nutrient intake GIP receptor activation is what sets tirzepatide apart
GLP-1 medications work through the same biological mechanisms at any age
Early signs, however, are hugely encouraging, mostly down to the fact that semaglutide, the drug that Ozempic and Wegovy are brand names for, works, by activating the GLP-1 receptors in the brain
Plant Power: Why Pea Protein Outshines Dairy for GLP-1 Users The notion that plant proteins are inferior is outdated
Promotes fat loss and metabolic improvements, not just temporary reductions in water or muscle mass
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial." New England Journal of Medicine, 2023
US$ 26.42
US$ 22.42
US$ 21.92
US$ 26.43
US$ 26.35
US$ 27.45
US$ 26.55
US$ 25.54
US$ 25.58
